KATHLEEN KOPACZ: Open Payments
NPI 1285392779 · CANON CITY, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 30 payments from 12 companies in 2025. Trend: 2023 $637 · 2024 $515 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $182 |
| Novo Nordisk Inc | 5 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $85 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 1 | $28 |
| Dexcom, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Gilead Sciences, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: KRYSTEXXA, Kerendia, Ozempic, EVENITY, Rybelsus, AUSTEDO XR, ZENPEP, OTEZLA.
Industry payments across CO — which companies pay providers there.
